Cargando…

Updates in Cardiac Amyloidosis: A Review

Detalles Bibliográficos
Autores principales:	Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Contemporary Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487372/ https://www.ncbi.nlm.nih.gov/pubmed/23130126 http://dx.doi.org/10.1161/JAHA.111.000364

Ejemplares similares

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis
por: Addison, Daniel, et al.
Publicado: (2021)

Systemic Amyloidosis in England: an epidemiological study
por: Pinney, Jennifer H, et al.
Publicado: (2013)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
por: Pinney, Jennifer H., et al.
Publicado: (2013)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
por: Wechalekar, A D, et al.
Publicado: (2017)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2017)

The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis
por: Banypersad, Sanjay M
Publicado: (2019)

The Evolving Epidemiology of Amyloidosis
por: Wechalekar, Ashutosh D.
Publicado: (2021)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Cardiac Transplantation: Update on a Road Less Traveled
por: Gupta, Tripti, et al.
Publicado: (2019)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

Early Denervation and Later Reinnervation of the Heart Following Cardiac Transplantation: A Review
por: Awad, Morcos, et al.
Publicado: (2016)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Degeneration of Bioprosthetic Heart Valves: Update 2020
por: Kostyunin, Alexander E., et al.
Publicado: (2020)

Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Delirium in the Cardiac Intensive Care Unit
por: Ibrahim, Khalil, et al.
Publicado: (2018)

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

Using Mobile Technology for Cardiac Rehabilitation: A Review and Framework for Development and Evaluation
por: Beatty, Alexis L., et al.
Publicado: (2013)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
por: Shmueli, Hezzy, et al.
Publicado: (2020)

Deferred autologous stem cell transplantation in systemic AL amyloidosis
por: Manwani, Richa, et al.
Publicado: (2018)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
por: Sharpley, Faye A., et al.
Publicado: (2019)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021)

2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations
por: Matiasz, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_npvsmric8mv2l5cpmeml5fp63q